ENHANCED EXTENDS PEPTIDE PLATFORM WITH TOPICAL GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT

by divibasicbldev | Apr 27, 2026 | Press Releases

— Prescription Topical Peptide Delivers a Consistent, Clinician-Prescribed Dose of GHK-Cu in Each Application —- Available Now on the Live Enhanced Platform –NEW YORK, April 27, 2026 /PRNewswire/ — Enhanced today announced an exciting new...

ENHANCED EXTENDS PEPTIDE PLATFORM WITH TOPICAL GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT

by divibasicbldev | Apr 27, 2026 | Press Releases

— Prescription Topical Peptide Delivers a Consistent, Clinician-Prescribed Dose of GHK-Cu in Each Application —- Available Now on the Live Enhanced Platform –NEW YORK, April 27, 2026 /PRNewswire/ — Enhanced today announced an exciting new...

ENHANCED EXTENDS PEPTIDE PLATFORM WITH TOPICAL GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT

by divibasicbldev | Apr 27, 2026 | Press Releases

— Prescription Topical Peptide Delivers a Consistent, Clinician-Prescribed Dose of GHK-Cu in Each Application —- Available Now on the Live Enhanced Platform –NEW YORK, April 27, 2026 /PRNewswire/ — Enhanced today announced an exciting new...

ENHANCED EXTENDS PEPTIDE PLATFORM WITH TOPICAL GHK-CU, FORMULATED UNDER MEDICAL COMMISSION OVERSIGHT

by divibasicbldev | Apr 27, 2026 | Press Releases

— Prescription Topical Peptide Delivers a Consistent, Clinician-Prescribed Dose of GHK-Cu in Each Application —- Available Now on the Live Enhanced Platform –NEW YORK, April 27, 2026 /PRNewswire/ — Enhanced today announced an exciting new...

PROPOSED BUSINESS COMBINATION BETWEEN ENHANCED LTD AND A PARADISE ACQUISITION CORP. IS MOVING TOWARDS CLOSING

by divibasicbldev | Apr 27, 2026 | Press Releases

NEW YORK and HONG KONG, April 27, 2026 /PRNewswire/ — A Paradise Acquisition Corp. (“A Paradise”) (NASDAQ: APAD), a special purpose acquisition company, is swiftly moving towards closing of the proposed business combination with Enhanced Ltd...